Cargando…

State-of-the-art considerations in small cell lung cancer brain metastases

BACKGROUND: Small cell lung cancer (SCLC) frequently leads to development of brain metastases. These unfortunately continue to be associated with short survival. Substantial advances have been made in our understanding of the underlying biology of disease. This understanding on the background of pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lukas, Rimas V., Gondi, Vinai, Kamson, David O., Kumthekar, Priya, Salgia, Ravi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642633/ https://www.ncbi.nlm.nih.gov/pubmed/29050358 http://dx.doi.org/10.18632/oncotarget.19333

Ejemplares similares

Advances in radiotherapy for brain metastases
por: Gondi, Vinai, et al.
Publicado: (2021)

Building Team Medicine in the Management of CNS Metastases
por: Baskaran, Archit B., et al.
Publicado: (2023)

CLRM-10 METIS (EF-25): A PIVOTAL, RANDOMIZED CONTROLLED STUDY OF TUMOR TREATING FIELDS IN PATIENTS WITH 1–10 BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
por: Mehta, Minesh, et al.
Publicado: (2022)

Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
por: Ascha, Mustafa S., et al.
Publicado: (2019)

Case Report of Bone Marrow-Sparing Proton Therapy Craniospinal Irradiation for Central Nervous System Myelomatosis
por: Kauffmann, Greg, et al.
Publicado: (2017)

TRLS-01. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS (TTFIELDS) FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
por: Mehta, Minesh, et al.
Publicado: (2019)

Immunotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: Clinical Challenges and Future Directions
por: Pathak, Ranjan, et al.
Publicado: (2021)

30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
por: Mehta, Minesh P, et al.
Publicado: (2020)

Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring MET exon 14 mutation: a research report
por: Roth, Katherine G., et al.
Publicado: (2020)

Differential Distribution of Brain Metastases from Non-Small Cell Lung Cancer Based on Mutation Status
por: Chen, Bihong T., et al.
Publicado: (2023)

The Cognitive Effects of Radiotherapy for Brain Metastases
por: Lehrer, Eric J., et al.
Publicado: (2022)

Updates on Molecular Targeted Therapies for Intraparenchymal CNS Metastases
por: Sharma, Akanksha, et al.
Publicado: (2021)

Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer
por: Chen, Bihong T., et al.
Publicado: (2021)

Using methylation profiling to diagnose systemic metastases of pleomorphic xanthoastrocytoma
por: Kam, Kwok-Ling, et al.
Publicado: (2019)

Multidisciplinary patient-centered management of brain metastases and future directions
por: Palmer, Joshua D, et al.
Publicado: (2020)

Factors affecting time to brain metastases for stage 2 and 3 breast cancer patients: A large single-institutional analysis with potential screening implications
por: Cao, Toni Q, et al.
Publicado: (2021)

Recent advances in managing brain metastasis
por: Kotecha, Rupesh, et al.
Publicado: (2018)

Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic
por: Matsui, Jennifer K., et al.
Publicado: (2022)

CLRM-11 ALK TYROSINE KINASE INHIBITOR THERAPY AND BRAIN METASTASES IN NON-SMALL CELL LUNG CANCER: IMPACT ON TUMOR SIZE AND DISTRIBUTION
por: Kamson, David Olayinka, et al.
Publicado: (2023)

Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors
por: Salgia, Ravi
Publicado: (2014)

Radiologic Assessment of Osteosarcoma Lung Metastases: State of the Art and Recent Advances
por: Chiesa, Anna Maria, et al.
Publicado: (2021)

Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?
por: Villaflor, Victoria M., et al.
Publicado: (2013)

Clinical outcomes for pleomorphic xanthoastrocytoma patients: an institutional experience
por: Sullivan, Jared, et al.
Publicado: (2023)

Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer
por: Puri, Neelu, et al.
Publicado: (2008)

Surgical and Peri-Operative Considerations for Brain Metastases
por: Gupta, Saksham, et al.
Publicado: (2021)

Pleomorphic xanthoastrocytoma: a brief review
por: Shaikh, Nawal, et al.
Publicado: (2019)

LSD1-targeted therapy—a multi-purpose key to unlock immunotherapy in small cell lung cancer
por: Sattler, Martin, et al.
Publicado: (2023)

State‐of‐the‐art considerations in post‐arrest care
por: Sonnier, Michael, et al.
Publicado: (2020)

Creativity, brain, and art: biological and neurological considerations
por: Zaidel, Dahlia W.
Publicado: (2014)

Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy data
por: Lin, Nancy U., et al.
Publicado: (2023)

Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases
por: Huang, Richard S P, et al.
Publicado: (2022)

State of the Art in Combination Immuno/Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis
por: Najafi, Masoumeh, et al.
Publicado: (2022)

Stamp out lung cancer
por: Salgia, Ravi
Publicado: (2008)

The Management of Brain Metastases in Non-Small Cell Lung Cancer
por: Owen, Scott, et al.
Publicado: (2014)

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma
por: Rybarczyk-Kasiuchnicz, Agnieszka, et al.
Publicado: (2021)

CLRM-09 MAPPING THE DISTRIBUTION AND CLINICAL ASSOCIATIONS OF BRAIN METASTASES IN RENAL CELL CARCINOMA
por: Kamson, David Olayinka, et al.
Publicado: (2023)

Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer
por: Won, Brian, et al.
Publicado: (2016)

Combined Checkpoint Inhibition and Chemotherapy: New Era of 1(st)-Line Treatment for Non-Small-Cell Lung Cancer
por: Wang, Chongkai, et al.
Publicado: (2019)

State-of-the-art of minimally invasive treatments of bone metastases
por: Li, Cun, et al.
Publicado: (2022)

Small Vessel Ischemic Disease of the Brain and Brain Metastases in Lung Cancer Patients
por: Mazzone, Peter J., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_r92c0241qlg0o4jnl96jrd2urn